Frangoul, H., Ho, T
The researchers concluded: Our findings suggest that co-administration of L-carnitine and synbiotic may be an encouraging therapeutic strategy for obesity and related cardiometabolic complications, possibly due to simultaneous targeting of multiple metabolic pathways, augmenting their bio-availability / function through potential complementary or synergistic mechanisms
Some were from the pharma side, some were other side
First, due to the lack of detailed individual information regarding sex, mental and physical conditions, and other concomitant diseases, subgroups that may show more beneficial effects of antioxidants could not be selected (Lu et al., 2022)
In spite of their limitations, these studies are the first to demonstrate a capacity of exogenously administered NAC to reach the CNS
What BMI do you need for insurance to cover Ozempic